Gut microbiota and oxalate homeostasis

Annals of Translational Medicine

Volumn 5, Issue 2, 2017, Pages

  Hatch, Marguerite ^a  

^a UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

Author keywords

Bifidobacterium sp.; Caecum; Distal colon; Hyperoxalemia; Hyperoxaluria; Intestinal oxalate transport; Lactobacillus sp.; Oxalobacter sp.; Small intestine; Urinary oxalate excretion; Urolithiasis

Indexed keywords

ALANINE GLYOXYLATE AMINOTRANSFERASE; OXALIC ACID; PROBIOTIC AGENT;

ARTICLE; BACTERIAL COLONIZATION; BIFIDOBACTERIUM; COMMENSAL; EXCRETION; HOMEOSTASIS; HUMAN; INTESTINE FLORA; KIDNEY FAILURE; KIDNEY GRAFT; LACTOBACILLUS; LIVER GRAFT; NEPHROLITHIASIS; NONHUMAN; OXALOBACTER; OXALOSIS 1; RODENT;

EID: 85010689300     PISSN: 23055839     EISSN: 23055847     Source Type: Journal    
DOI: 10.21037/atm.2016.12.70     Document Type: Article

References (55)

1. Worcester EM, Coe FL. Nephrolithiasis. Prim Care 2008;35:369-91, vii.
2. Hatch M. Oxalate status in stone-formers. Two distinct hyperoxaluric entities. Urol Res 1993;21:55-9.
3. Holmes RP, Assimos DG. Glyoxylate synthesis, and its modulation and influence on oxalate synthesis. J Urol 1998;160:1617-24.
4. Holmes RP, Goodman HO, Assimos DG. Contribution of dietary oxalate to urinary oxalate excretion. Kidney Int 2001;59:270-6.
5. Kasidas GP. Assay of oxalate and glycollate in urine. In: Rose GA. editor. Oxalate metabolism in relation to urinary stone. Berlin Heidelberg New York: Springer-Verlag, 1988:7-26.
6. Harris AH, Freel RW, Hatch M. Serum oxalate in human beings and rats as determined with the use of ion chromatography. J Lab Clin Med 2004;144:45-52.
7. Wilson DM, Liedtke RR. Modified enzyme-based colorimetric assay of urinary and plasma oxalate with improved sensitivity and no ascorbate interference: reference values and sample handling procedures. Clin Chem 1991;37:1229-35.
8. Petrarulo M, Cerelli E, Marangella M, et al. Assay of plasma oxalate with soluble oxalate oxidase. Clin Chem 1994;40:2030-4.
9. Hönow R, Simon A, Hesse A. Interference-free sample preparation for the determination of plasma oxalate analyzed by HPLC-ER: preliminary results from calcium oxalate stone-formers and non-stone-formers. Clin Chim Acta 2002;318:19-24.
10. Hatch M. Spectrophotometric determination of oxalate in whole blood. Clin Chim Acta 1990;193:199-202.
11. Rolton HA, McConnell KN, Modi KS, et al. A simple, rapid assay for plasma oxalate in uraemic patients using oxalate oxidase, which is free from vitamin C interference. Clin Chim Acta 1989;182:247-54.
12. Kasidas GP, Rose GA. Measurement of plasma oxalate in healthy subjects and in patients with chronic renal failure using immobilised oxalate oxidase. Clin Chim Acta 1986;154:49-58.
13. Whittamore JM, Hatch M. The role of intestinal oxalate transport in hyperoxaluria and the formation of kidney stones in animals and man. Urolithiasis 2016. [Epub ahead of print].
14. Hatch M, Freel RW. The roles and mechanisms of intestinal oxalate transport in oxalate homeostasis. Semin Nephrol 2008;28:143-51.
15. Knight J, Deora R, Assimos DG, et al. The genetic composition of Oxalobacter formigenes and its relationship to colonization and calcium oxalate stone disease. Urolithiasis 2013;41:187-96.
16. Asplin JR. The management of patients with enteric hyperoxaluria. Urolithiasis 2016;44:33-43.
17. Liebman M, Al-Wahsh IA. Probiotics and other key determinants of dietary oxalate absorption. Adv Nutr 2011;2:254-60.
18. Abratt VR, Reid SJ. Oxalate-degrading bacteria of the human gut as probiotics in the management of kidney stone disease. Adv Appl Microbiol 2010;72:63-87.
19. Allison MJ, Dawson KA, Mayberry WR, et al. Oxalobacter formigenes gen. nov., sp. nov.: oxalate-degrading anaerobes that inhabit the gastrointestinal tract. Arch Microbiol 1985;141:1-7.
20. Dawson KA, Allison MJ, Hartman PA. Characteristics of anaerobic oxalate-degrading enrichment cultures from the rumen. Appl Environ Microbiol 1980;40:840-6.
21. Hatch M, Cornelius J, Allison M, et al. Oxalobacter sp. reduces urinary oxalate excretion by promoting enteric oxalate secretion. Kidney Int 2006;69:691-8.
22. Sidhu H, Schmidt ME, Cornelius JG, et al. Direct correlation between hyperoxaluria/oxalate stone disease and the absence of the gastrointestinal tract-dwelling bacterium Oxalobacter formigenes: possible prevention by gut recolonization or enzyme replacement therapy. J Am Soc Nephrol 1999;10 Suppl 14:S334-40.
23. Hatch M, Freel RW. Angiotensin II involvement in adaptive enteric oxalate excretion in rats with chronic renal failure induced by hyperoxaluria. Urol Res 2003;31:426-32.
24. Hatch M, Freel RW, Vaziri ND. Regulatory aspects of oxalate secretion in enteric oxalate elimination. J Am Soc Nephrol 1999;10 Suppl 14:S324-8.
25. Hatch M, Freel RW. A human strain of Oxalobacter (HC-1) promotes enteric oxalate secretion in the small intestine of mice and reduces urinary oxalate excretion. Urolithiasis 2013;41:379-84.
26. Hatch M, Gjymishka A, Salido EC, et al. Enteric oxalate elimination is induced and oxalate is normalized in a mouse model of primary hyperoxaluria following intestinal colonization with Oxalobacter. Am J Physiol Gastrointest Liver Physiol 2011;300:G461-9.
27. Klimesova K, Whittamore JM, Hatch M. Bifidobacterium animalis subsp. lactis decreases urinary oxalate excretion in a mouse model of primary hyperoxaluria. Urolithiasis 2015;43:107-17.
28. Turroni S, Vitali B, Bendazzoli C, et al. Oxalate consumption by lactobacilli: evaluation of oxalyl-CoA decarboxylase and formyl-CoA transferase activity in Lactobacillus acidophilus. J Appl Microbiol 2007;103:1600-9.
29. Hoppe B, Groothoff JW, Hulton SA, et al. Efficacy and safety of Oxalobacter formigenes to reduce urinary oxalate in primary hyperoxaluria. Nephrol Dial Transplant 2011;26:3609-15.
30. Jiang J, Knight J, Easter LH, et al. Impact of dietary calcium and oxalate, and Oxalobacter formigenes colonization on urinary oxalate excretion. J Urol 2011;186:135-9.
31. Lieske JC, Tremaine WJ, De Simone C, et al. Diet, but not oral probiotics, effectively reduces urinary oxalate excretion and calcium oxalate supersaturation. Kidney Int 2010;78:1178-85.
32. Siener R, Bade DJ, Hesse A, et al. Dietary hyperoxaluria is not reduced by treatment with lactic acid bacteria. J Transl Med 2013;11:306.
33. Hoppe B, von Unruh G, Laube N, et al. Oxalate degrading bacteria: new treatment option for patients with primary and secondary hyperoxaluria? Urol Res 2005;33:372-5.
34. Hoppe B, Beck B, Gatter N, et al. Oxalobacter formigenes: a potential tool for the treatment of primary hyperoxaluria type 1. Kidney Int 2006;70:1305-11.
35. Lieske JC, Goldfarb DS, De Simone C, et al. Use of a probiotic to decrease enteric hyperoxaluria. Kidney Int 2005;68:1244-9.
36. Goldfarb DS, Modersitzki F, Asplin JR. A randomized, controlled trial of lactic acid bacteria for idiopathic hyperoxaluria. Clin J Am Soc Nephrol 2007;2:745-9.
37. Siener R, Bangen U, Sidhu H, et al. The role of Oxalobacter formigenes colonization in calcium oxalate stone disease. Kidney Int 2013;83:1144-9.
38. Campieri C, Campieri M, Bertuzzi V, et al. Reduction of oxaluria after an oral course of lactic acid bacteria at high concentration. Kidney Int 2001;60:1097-105.
39. Neuhaus TJ, Belzer T, Blau N, et al. Urinary oxalate excretion in urolithiasis and nephrocalcinosis. Arch Dis Child 2000;82:322-6.
40. Troxel SA, Sidhu H, Kaul P, et al. Intestinal Oxalobacter formigenes colonization in calcium oxalate stone formers and its relation to urinary oxalate. J Endourol 2003;17:173-6.
41. Kwak C, Kim HK, Kim EC, et al. Urinary oxalate levels and the enteric bacterium Oxalobacter formigenes in patients with calcium oxalate urolithiasis. Eur Urol 2003;44:475-81.
42. Mikami K, Akakura K, Takei K, et al. Association of absence of intestinal oxalate degrading bacteria with urinary calcium oxalate stone formation. Int J Urol 2003;10:293-6.
43. Kumar R, Mukherjee M, Bhandari M, et al. Role of Oxalobacter formigenes in calcium oxalate stone disease: a study from North India. Eur Urol 2002;41:318-22.
44. Mittal RD, Kumar R, Mittal B, et al. Stone composition, metabolic profile and the presence of the gut-inhabiting bacterium Oxalobacter formigenes as risk factors for renal stone formation. Med Princ Pract 2003;12:208-13.
45. Kelly JP, Curhan GC, Cave DR, et al. Factors related to colonization with Oxalobacter formigenes in U.S. adults. J Endourol 2011;25:673-9.
46. Barnett C, Nazzal L, Goldfarb DS, et al. The Presence of Oxalobacter formigenes in the Microbiome of Healthy Young Adults. J Urol 2016;195:499-506.
47. Lange JN, Wood KD, Wong H, et al. Sensitivity of human strains of Oxalobacter formigenes to commonly prescribed antibiotics. Urology 2012;79:1286-9.
48. Mittal RD, Kumar R, Bid HK, et al. Effect of antibiotics on Oxalobacter formigenes colonization of human gastrointestinal tract. J Endourol 2005;19:102-6.
49. Kharlamb V, Schelker J, Francois F, et al. Oral antibiotic treatment of Helicobacter pylori leads to persistently reduced intestinal colonization rates with Oxalobacter formigenes. J Endourol 2011;25:1781-5.
50. Daniel SL, Hartman PA, Allison MJ. Microbial degradation of oxalate in the gastrointestinal tracts of rats. Appl Environ Microbiol 1987;53:1793-7.
51. Allison MJ, Daniel SL, Cornick NA. Oxalate-degrading Bacteria. In: Khan SR. editor. Calcium Oxalate in Biological Systems. Boca Raton New York London Tokyo: CRC Press, 1995:131-68.
52. Canales BK, Hatch M. Kidney stone incidence and metabolic urinary changes after modern bariatric surgery: review of clinical studies, experimental models, and prevention strategies. Surg Obes Relat Dis 2014;10:734-42.
53. Hatch M, Canales BK. The mechanistic basis of hyperoxaluria following gastric bypass in obese rats. Urolithiasis 2016;44:221-30.
54. Sidhu H, Allison MJ, Chow JM, et al. Rapid reversal of hyperoxaluria in a rat model after probiotic administration of Oxalobacter formigenes. J Urol 2001;166:1487-91.
55. Ussar S, Griffin NW, Bezy O, et al. Interactions between Gut Microbiota, Host Genetics and Diet Modulate the Predisposition to Obesity and Metabolic Syndrome. Cell Metab 2015;22:516-30.